Evidence map›Paper›PMID 33724954›Full record

ArticleJCI insight2021

Obesity results in adipose tissue T cell exhaustion.

Cara E Porsche, Jennifer B Delproposto, Lynn Geletka, Robert O'Rourke, Carey N Lumeng

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Metabolic Reprogramming and ILC2 Plasticity in Obesity-related Asthma.Clinical reviews in allergy & immunology · 2026
    Review
  6. T cell dysregulation and remodeling in pediatric obesity and weight loss.bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Cara E PorscheGraduate Program in Immunology.
Jennifer B DelpropostoDepartment of Pediatrics and Communicable Diseases, and.
Lynn GeletkaDepartment of Pediatrics and Communicable Diseases, and.
Robert O'RourkeDepartment of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Carey N LumengGraduate Program in Immunology.
Center for Non-Communicable Diseases · PKInstitute of Immunology · HRUniversity of Michigan · US

Funding

Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RANDY J SEELEY · 2010 to 2026
$20.3M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Regulation of Adipose Tissue Inflammation By Antigen Presenting CellsR01DK090262 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, CAREY N · 2011 to 2024
$5.3M
Adipose Tissue Macrophage Control of Metabolic Dysfunction in DiabetesR01DK115190 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, CAREY N, O'ROURKE, ROBERT W · 2017 to 2020
$2.3M
Training Program in Translational Cardiovascular Research and EntrepreneurshipT32HL125242 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MICHELE, DANIEL E · 2015 to 2024
$1.9M
Mechanisms of CD4+ adipose tissue T cell activation in diabetesF31DK118811 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PORSCHE, CARA E · 2018 to 2019
$82k
CSRD VA I01 CX001811NHLBI NIH HHS T32 HL125242NIAID NIH HHS T32 AI007413NIDDK NIH HHS F31 DK118811NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R01 DK090262NIDDK NIH HHS R01 DK115190
6 · The paper itself

Abstract

Despite studies implicating adipose tissue T cells (ATT) in the initiation and persistence of adipose tissue inflammation, fundamental gaps in knowledge regarding ATT function impedes progress toward understanding how obesity influences adaptive immunity. We hypothesized that ATT activation and function would have tissue-resident-specific properties and that obesity would potentiate their inflammatory properties. We assessed ATT activation and inflammatory potential within mouse and human stromal vascular fraction (SVF). Surprisingly, murine and human ATTs from obese visceral white adipose tissue exhibited impaired inflammatory characteristics upon stimulation. Both environmental and cell-intrinsic factors are implicated in ATT dysfunction. Soluble factors from obese SVF inhibit ATT activation. Additionally, chronic signaling from macrophage major histocompatibility complex II (MHCII) is necessary for ATT impairment in obese adipose tissue but is independent of increased PD1 expression. To assess intracellular signaling mechanisms responsible for ATT inflammation impairments, single-cell RNA sequencing of ATTs was performed. ATTs in obese adipose tissue exhibit enrichment of genes characteristic of T cell exhaustion and increased expression of coinhibitory receptor Btla. In sum, this work suggests that obesity-induced ATTs have functional characteristics and gene expression resembling T cell exhaustion induced by local soluble factors and cell-to-cell interactions in adipose tissue.

Indexed as

Adaptive ImmunityAdipose TissueAdipose Tissue, WhiteAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHistocompatibility Antigens Class IIHumansIntra-Abdominal FatMacrophagesMaleMiceMiddle AgedObesityProgrammed Cell Death 1 ReceptorReceptors, ImmunologicBTLA protein, humanBTLA protein, mouseHistocompatibility Antigens Class IIProgrammed Cell Death 1 ReceptorReceptors, ImmunologicAdipose tissueInflammationMetabolismObesityT cells

Identifiers

PMID33724954
PMCPMC8119198
OpenAlexW3137140839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.